ArticleFrontiers in immunology2021

TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Yuchuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.